Valneva SE (VALN)
5.16
-0.10
(-1.90%)
USD |
NASDAQ |
Jun 11, 14:10
Valneva Total Liabilities (Quarterly) : 340.26M for March 31, 2026
Total Liabilities (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Total Liabilities (Quarterly) Data
| Date | Value |
|---|---|
| March 31, 2026 | 340.26M |
| December 31, 2025 | 343.72M |
| September 30, 2025 | 349.86M |
| June 30, 2025 | 335.95M |
| March 31, 2025 | 331.61M |
| December 31, 2024 | 340.19M |
| September 30, 2024 | 333.86M |
| June 30, 2024 | 321.84M |
| March 31, 2024 | 338.69M |
| December 31, 2023 | 376.84M |
| September 30, 2023 | 384.35M |
| June 30, 2023 | 383.88M |
| March 31, 2023 | 418.52M |
| December 31, 2022 | 440.56M |
| September 30, 2022 | 522.25M |
| June 30, 2022 | 660.57M |
| March 31, 2022 | 700.20M |
| December 31, 2021 | 745.38M |
| September 30, 2021 | |
| June 30, 2021 | 792.22M |
| March 31, 2021 | 613.22M |
| December 31, 2020 | 467.89M |
| September 30, 2020 | 437.93M |
| June 30, 2020 | 312.56M |
| March 31, 2020 | 157.37M |
| Date | Value |
|---|---|
| December 31, 2019 | 156.02M |
| September 30, 2019 | 129.76M |
| June 30, 2019 | 133.72M |
| March 31, 2019 | 117.40M |
| December 31, 2018 | 110.48M |
| September 30, 2018 | 99.44M |
| June 30, 2018 | 104.53M |
| March 31, 2018 | 112.88M |
| December 31, 2017 | 116.09M |
| September 30, 2017 | 112.92M |
| June 30, 2017 | 114.12M |
| March 31, 2017 | 106.00M |
| December 31, 2016 | 112.68M |
| September 30, 2016 | 118.43M |
| June 30, 2016 | 117.22M |
| March 31, 2016 | 122.60M |
| December 31, 2015 | 142.14M |
| September 30, 2015 | 144.11M |
| June 30, 2015 | 147.20M |
| March 31, 2015 | 141.98M |
| December 31, 2014 | 124.72M |
| September 30, 2014 | 130.73M |
| June 30, 2014 | 140.31M |
| March 31, 2014 | 143.44M |
| December 31, 2013 |
Total Liabilities Definition
Liabilities are a main portion of the balance sheet of a company that measure outstanding payables/obligations. A few examples of liabilties of a company include accounts payable, current debt, and capital lease obligations. From an accounting perspective, the balance sheet equation is Liabilties = Assets - Shareholder's Equity.
Total Liabilities (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Total Liabilities (Quarterly) Benchmarks
| Pfizer Inc. | 117.21B |
| Nicox SA | -- |
| DBV Technologies SA | 58.50M |
| Cellectis SA | 229.27M |
| Inventiva SA | -- |
Total Liabilities (Quarterly) Related Metrics
| Total Assets (Quarterly) | 428.63M |
| Shareholders Equity (Quarterly) | 88.37M |
| Debt to Equity Ratio | 2.732 |
| Current Ratio | 2.138 |
| Net Debt Paydown Yield | -0.65% |